PRAX Praxis Precision Medicines, Inc
$267.59▲ +0.07%
Healthcare
Other
Volume 387.9K
Avg Volume (10D) 611.6K
Key Metrics & Fundamentals
Market Cap
$7.47B
P/E Ratio
–
Div Yield
0.00%
52W Range
154.45 - 392.70
% vs 50 MA
-12.69%
% vs 200 MA
-15.00%
RSI-14
46.5
MACD Histogram
+3.7900
Beta (1Y vs SPY)
1.24
Free Cash Flow
-$78.56M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$96.87M
COGS
–
Operating Exp
$96.90M
Operating Income
-$96.90M
EBIT
-$96.90M
Pretax Income
-$83.72M
Net Income
-$83.72M
EPS (Diluted)
-2.87
Price & Volume History
Loading chart…
Recent News
Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation
GlobeNewswire · Oct 27, 2026 4:01 PM ET
Epilepsy Market Set to Grow During the Forecast Period (2026-2036) as Novel Antiseizure Therapies Gain Momentum | DelveInsight
PR Newswire · Oct 27, 2026 10:31 AM ET
Is Praxis Precision Medicines (PRAX) Priced Too Highly On Book Value?
Simply Wall St. · Oct 18, 2026 5:12 PM ET
Workday downgraded, Fox Corp. upgraded: Wall Street's top analyst calls
The Fly · Oct 16, 2026 9:38 AM ET
JPMorgan Initiates Praxis Precision Medicines at Overweight With $700 Price Target
MT Newswires · Oct 16, 2026 7:32 AM ET
UBS Initiates Praxis Precision Medicines at Buy With $706 Price Target
MT Newswires · Oct 15, 2026 7:41 AM ET
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 2, 2026 4:01 PM ET
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 3, 2026 4:01 PM ET
Praxis Precision Medicines Could Be Approaching 'Perfect Trifecta,' Oppenheimer Says
MT Newswires · Aug 17, 2026 11:21 AM ET
Praxis (PRAX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 12:29 PM ET
Financial Overview - Income Statement
Quarterly
Dec 2024
See PRAX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.